Key facts
- This page summarizes Nicolas Sokolow's Form 4 filing for Cadre Holdings, Inc. (CDRE).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 20 Mar 2024, 16:16.
Nicolas Sokolow - 18 Mar 2024 Form 4 Insider Report for Cadre Holdings, Inc. (CDRE)
- Reporting relationship
- Director
- Issuer ticker
- CDRE
- Reported as of
- 18 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Mar 2024, 16:16:26 UTC
- Prior SEC filing
- 13 Mar 2024
- Next SEC filing
- 03 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nicolas Sokolow
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Nicolas Sokolow filed Form 4 for Cadre Holdings, Inc. (CDRE) on 20 Mar 2024.
Change
- Previous filing in this sequence was filed on 13 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDRE
transaction
Common Stock, $.0001 par value ("Common Stock")
Options Exercise
- Transaction value
- Shares
- +11,000
- Change %
- +21%
- Price
- Shares after
- 62,347
- Date
- 18 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
CDRE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 587,620
- Date
- 18 Mar 2024
- Ownership
- See Footnote
- Footnotes
- F2, F5
CDRE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 252,701
- Date
- 18 Mar 2024
- Ownership
- See Footnote
- Footnotes
- F3, F5
CDRE
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 84,231
- Date
- 18 Mar 2024
- Ownership
- See Footnote
- Footnotes
- F4, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDRE
transaction
Derivative
Phantom Stock
Options Exercise
- Transaction value
- $0
- Shares
- -11,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 18 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,000
- Exercise price
- Footnotes
- F1
CDRE
transaction
Derivative
Stock Option (right to purchase)
Award
- Transaction value
- $0
- Shares
- +16,000
- Change %
- Price
- $0.000000
- Shares after
- 16,000
- Date
- 18 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,000
- Exercise price
- $34.66
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
On March 9, 2024, the Reporting Person was granted a phantom stock award under the Safariland Group Amended and Restated 2021 Phantom Restricted Share Plan consisting of 33,000 shares of phantom stock. Each share of phantom stock is the economic equivalent of one share of Cadre Holdings, Inc. (the "Issuer") Common Stock. 11,000 shares of phantom stock vested and became non-forfeitable on each of March 18, 2022, March 18, 2023 and March 18, 2024, respectively.
Footnote F2
The securities reported herein are owned by ST Investors Fund, LLC, a limited liability company of which the Reporting Person is the general manager.
Footnote F3
The securities reported herein are owned by Korsak Holdings, LLC, a limited liability company of which the Reporting Person is the general manager.
Footnote F4
The securities reported herein are owned by Madetys Investments, LLC, a limited liability company of which the Reporting Person is the general manager.
Footnote F5
The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities.
Footnote F6
16,000 options to purchase shares of the Issuer's Common Stock were granted under the Issuer's 2021 Stock Incentive Plan. Options to purchase 4,000 shares of the Issuer's Common Stock will vest and become exercisable in four equal consecutive quarterly tranches on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, respectively.